Trial intelligence / Profile preview

Pentoxifylline in Newly-Diagnosed Biliary Atresia

NCT01774487Phase 2Terminated

Sponsor
Baylor College of Medicine
Start
Feb 2013
Primary completion
Feb 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of pentoxifylline in biliary atresia, sponsored by Baylor College of Medicine. Started Feb 2013; status: terminated.

02

Drugs

pentoxifylline
03

Conditions

biliary atresia

Beyond the preview

Go deeper on NCT01774487.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01774487.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call